274 related articles for article (PubMed ID: 36830020)
1. Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment.
Butterfield DA
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36830020
[TBL] [Abstract][Full Text] [Related]
2. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.
Sultana R; Banks WA; Butterfield DA
J Neurosci Res; 2010 Feb; 88(3):469-77. PubMed ID: 19774677
[TBL] [Abstract][Full Text] [Related]
4. Methionine-35 of aβ(1-42): importance for oxidative stress in Alzheimer disease.
Butterfield DA; Sultana R
J Amino Acids; 2011; 2011():198430. PubMed ID: 22312456
[TBL] [Abstract][Full Text] [Related]
5. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
Bradfield NI; Ellis KA; Savage G; Maruff P; Burnham S; Darby D; Lautenschlager NT; Martins RN; Masters CL; Rainey-Smith SR; Robertson J; Rowe C; Woodward M; Ames D
Alzheimer Dis Assoc Disord; 2018; 32(3):190-196. PubMed ID: 29561277
[TBL] [Abstract][Full Text] [Related]
6. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
Butterfield DA
Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
Cenini G; Sultana R; Memo M; Butterfield DA
J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
[TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Effects of Walnuts on Cognition and Brain Health.
Chauhan A; Chauhan V
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32093220
[TBL] [Abstract][Full Text] [Related]
10. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.
Cenini G; Sultana R; Memo M; Butterfield DA
Free Radic Biol Med; 2008 Jul; 45(1):81-5. PubMed ID: 18439434
[TBL] [Abstract][Full Text] [Related]
11. Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories.
Butterfield DA
Ageing Res Rev; 2020 Dec; 64():101049. PubMed ID: 32205035
[TBL] [Abstract][Full Text] [Related]
12. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
Bader Lange ML; Cenini G; Piroddi M; Abdul HM; Sultana R; Galli F; Memo M; Butterfield DA
Neurobiol Dis; 2008 Mar; 29(3):456-64. PubMed ID: 18077176
[TBL] [Abstract][Full Text] [Related]
13. Memory and Executive Dysfunction Predict Complex Activities of Daily Living Impairment in Amnestic Multi-Domain Mild Cognitive Impairment.
García-García-Patino R; Benito-León J; Mitchell AJ; Pastorino-Mellado D; García García R; Ladera-Fernández V; Vicente-Villardón JL; Perea-Bartolomé MV; Cacho J
J Alzheimers Dis; 2020; 75(3):1061-1069. PubMed ID: 32390622
[TBL] [Abstract][Full Text] [Related]
14. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
Park SJ; Lee JE; Lee KS; Kim JS
Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease.
Butterfield DA; Boyd-Kimball D
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32887505
[TBL] [Abstract][Full Text] [Related]
16. Copolymer-1 as a potential therapy for mild cognitive impairment.
Incontri-Abraham D; Esparza-Salazar FJ; Ibarra A
Brain Cogn; 2022 Oct; 162():105892. PubMed ID: 35841771
[TBL] [Abstract][Full Text] [Related]
17. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
18. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
Lovell MA; Markesbery WR
J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
[TBL] [Abstract][Full Text] [Related]
19. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study.
Acosta-Baena N; Sepulveda-Falla D; Lopera-Gómez CM; Jaramillo-Elorza MC; Moreno S; Aguirre-Acevedo DC; Saldarriaga A; Lopera F
Lancet Neurol; 2011 Mar; 10(3):213-20. PubMed ID: 21296022
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
